SG
XRTX

StoneX Group’s XORTX Therapeutics XRTX Stock Holding History

StoneX Group’s Portfolio XRTX Stock Details XRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.9K Buy
+16,369
New +$39.1K ﹤0.01% 1251

Other funds holding XRTX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

StoneX Group's XRTX Position: Q2 2026 in Review

StoneX Group opened a new position in XORTX Therapeutics (XRTX) in Q2 2026: 16,369 shares worth $37.9K. The stake represents ﹤0.01% of the portfolio and ranks #1251 among its holdings.

6 funds tracked by Wall St. Rank hold XRTX as of Q2 2026.

  • StoneX Group held 16,369 shares of XORTX Therapeutics worth $37.9K as of Q2 2026.
  • XORTX Therapeutics was a new StoneX Group position in Q2 2026.
  • XORTX Therapeutics made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1251 holding.
  • 6 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.